Complicated iatrogenic allogenosis presentation of two clinical cases

Authors

  • Daniela González Alfonso Hospital Clínico Quirúrgico Hermanos Ameijeiras
  • Alicia María Tamayo Carbón Hospital Clínico Quirúrgico “Hermanos Ameijeiras”, La Habana, Cuba.

Abstract

The need to correct aesthetic defects, age-related wrinkles, and congenital or acquired skin depressions has led to the use of multiple adjuvants, which, once injected, offer immediate results without long-term effects on health. This is how the disease caused by modeling agents, defined by Felipe Coiffman in 2008 as iatrogenic allogenosis, arises. Among the most commonly used are: mineral oil, animal fat, petroleum jelly, silicone, paraffin, and biopolymers, which, when injected, behave like foreign bodies, triggering granulomatous reactions as part of the immune response. The first manifestations may appear 6 hours to 30 years after injection and may occur in outbreaks lasting 1 to 3 weeks every 2 months with local and systemic symptoms. Locally, there is redness, pain, increased volume and temperature in the area, nodules, edema, fibrosis, keloids, abscesses, and fistulas. Systemic symptoms include fever, arthralgia, fatigue, and general malaise. Improvement may be spontaneous or with medical treatment, although a small number of patients may be asymptomatic. We present two clinical cases diagnosed with complicated iatrogenic gluteal allogenosis, treated in the Plastic Surgery Department of the Hermanos Ameijeiras Surgical Clinical Hospital, Havana, Cuba. Both patients underwent different surgical techniques, achieving satisfactory results without postoperative complications and favorable clinical outcomes. Iatrogenic allogenosis is a health problem, which is why we insist on raising awareness about the prevention of this incurable disease.

Downloads

Download data is not yet available.

References

1.Coiffman F. Alogenosis iatrogénica. Una nueva enfermedad. Cir. plást. iberolatinoam. 2008[citado 16/8/2026]; 34(1):01-10. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0376-78922008000100002&lng=es .

2.Hormaza Jaramillo A, Peñaloza Gonzalez D, Benavides Ibarra SA, Calvache Hernandez N, Muñoz Garcia LE, Hidalgo Cardona A, et al. Severe Complications Due to Biopolymers in a Patient With Autoimmune Disease: A Case Report and Review of the Literature. Aesthet Surg J Open Forum. 2025[citado 16/8/2026]; 7:ojaf099. Disponible en: https://academic.oup.com/asjopenforum/article/doi/10.1093/asjof/ojaf099/8221645

3.Contreras Díaz BR, Córdova Gómez A, Rubio Gómez L, Ruiz Velasco RC. Enfermedad por modelantes, síndrome autoinmune inducido por adyuvantes y otras enfermedades de la vanidad. Cir. gen. 2021[citado04/05/2025]; 43(4): 234-42. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1405-00992021000400234&lng=es

4.Pachón Suarez JE, Rizo Tello VZ, Rozo Cifuentes RC, Pores Cuadros AM, Salazar M. Biopolymers: Histopathologic Case Series of Patients with Permanent Synthetic Fillers Presenting Chronic Granulomatous Reaction and Hypercalcemia. Plast Reconstr Surg Glob Open. 2024[citado04/05/2025]; 12(10):e6159. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC11479478/

5.Tamayo Carbón AM, Castellanos Prada AR, Aveiro-Róbalo TR. Alogenosis iatrogénica y enfermedades reumáticas. Rev Cuba Reumatol. 2018[citado 04/05/2025]; 20(2). Disponible en: https://revreumatologia.sld.cu/index.php/reumatologia/article/view/615/pdf .

6.Narváez Riera D, Ortiz G. Alogenosis por biomateriales, nuestra experiencia. Cir. plást. iberolatinoam. 2022[citado 05/05/2025]; 48(4): 453-58. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0376-78922022000400012

7.Tamayo Carbón AM, Medina Robainas RE, Cuastumal Figueroa DK, García Batista FM, Gutiérrez Reyes A, González Meraz OZ. Caracterización de la Alogenosis Iatrogénica en la población cubana. Panorama. Cuba y Salud. 2021[citado 24/05/2025]; 16(3). Disponible en: https://revpanorama.sld.cu/index.php/panorama/article/view/1316

8.Montealegre G, Uribe R, Martinez Ceballos MA, Rojas Villarraga A. ASIA syndrome symptoms induced by gluteal biopolymer injections: Case-series and narrative review. Toxicol Rep. 2021[citado 24/05/2025]; 8:303-14. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33552929/

9.Tamayo Carbón AM, Bencosme Escarramán YY, Medina Robainas RE. HALLAZGOS QUIRÚRGICOS EN PACIENTES CON ALOGENOSIS IATROGÉNICA. Rev Cient Cienc Méd. 2021[citado 24/05/2025]; 24(1): 43-51. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1817-74332021000100043&lng=es

10.Duarte y Sanchez A, Hedo Toledo AH, Pradel Mora J, Gómez Recilla V. Complicación tardía tras infiltración de biopolímeros en glúteos. Cir. plást. Iberolatinoam. 2016[citado 24/05/2025]; 42(4): 385-89. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0376-78922016000400011&lng=es

Published

2026-08-31

How to Cite

1.
González Alfonso D, Tamayo Carbón AM. Complicated iatrogenic allogenosis presentation of two clinical cases. MEDISAN.Revista médica Santiago [Internet]. 2026 Aug. 31 [cited 2026 Sep. 20];30:e5475. Available from: https://medisan.sld.cu/index.php/san/article/view/5475

Issue

Section

Case Reports